EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Becton Dickinson's enterprise value is $68,686 Mil.
Becton Dickinson's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was $4,650 Mil. Therefore, Becton Dickinson's EV-to-EBITDA for today is 14.77.
The historical rank and industry rank for Becton Dickinson's EV-to-EBITDA or its related term are showing as below:
BDX'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 14.34 Med: 20.23 Max: 39.49
Current: 14.77
During the past 13 years, the highest EV-to-EBITDA of Becton Dickinson was 39.49. The lowest was 14.34. And the median was 20.23.
BDX's EV-to-EBITDA is ranked better than 52.83% of 494
companies
in the Medical Devices & Instruments industry
Industry Median: 15.495
vs BDX: 14.77
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Becton Dickinson EV-to-EBITDA Historical Data
The historical data trend for Becton Dickinson's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Becton Dickinson's EV-to-EBITDA
For the Medical Instruments & Supplies subindustry, Becton Dickinson's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Becton Dickinson's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Becton Dickinson's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Becton Dickinson's EV-to-EBITDA falls into.
Becton Dickinson's current Enterprise Value is $68,686 Mil.
Becton Dickinson's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $4,650 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Becton Dickinson's PE Ratio (TTM) for today is calculated as:
Becton Dickinson's share price for today is $175.40.
Becton Dickinson's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.240.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Thank you for viewing the detailed overview of Becton Dickinson's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BDX has been successfully added to your 